Alzamend Neuro (ALZN) Capital Expenditures (2023 - 2025)

Alzamend Neuro has disclosed Capital Expenditures across 3 years of filings, most recently posting $210000.0 for Q2 2025.

• In Q2 2025, Capital Expenditures changed N/A year-over-year to $210000.0; the TTM figure through Apr 2025 stood at $300000.0 (up 103.74% YoY), while the FY2025 annual figure was $300000.0, up 103.74% from the prior year.
• Capital Expenditures came in at $210000.0 for Q2 2025 at Alzamend Neuro, up from $90000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $210000.0 in Q2 2025 to a low of $90000.0 in Q3 2024.
• Average Capital Expenditures over 3 years is $149081.0, with a median of $147243.0 recorded in 2023.
• The largest YoY upside for Capital Expenditures was 38.88% in 2024 against a maximum downside of 38.88% in 2024.
• Over 3 years, Capital Expenditures stood at $147243.0 in 2023, then slumped by 38.88% to $90000.0 in 2024, then jumped by 133.33% to $210000.0 in 2025.
• Per Business Quant data, the three most recent Capital Expenditures figures were $210000.0 in Q2 2025, $90000.0 in Q3 2024, and $147243.0 in Q3 2023.